Objective: The aim of this study was to determine whether chronic b-adrenergic receptor (b-AR) stimulation induces proliferation of human cardiac fibroblasts and to investigate the mechanism(s) involved. Methods and results: In vitro cultures of human cardiac fibroblasts were established from biopsies of right atrial appendage. RT-PCR analysis and pharmacological studies demonstrated that these cells express predominantly the b -AR subtype coupled to activation of adenylyl cyclase and p44 / 42 mitogen-activated protein 2 kinase (MAPK). Proliferation was determined by cell counting over a 6-day period in medium containing 2.5% fetal calf serum (control) or supplemented with the non-selective b-AR agonist isoproterenol (ISO). ISO induced a concentration-dependent increase in cardiac fibroblast proliferation, which was maximal at 1 mmol / l. This increased proliferation was inhibited by the b -AR-selective antagonist 2 ICI-118,551, but not the b -AR-selective antagonist atenolol. Direct activation of adenylyl cyclase alone (0.1-10 mmol / l forskolin) 1 stimulated cyclic AMP production and MAPK activation, but did not induce cell proliferation. Since catecholamines are not considered to be 'classical' growth factors, we subsequently investigated whether b -AR stimulation results in secretion of growth factors that are able 2 to stimulate proliferation in an autocrine manner. Conditioned medium obtained from cardiac fibroblasts treated with ISO for 48 h increased proliferation of parallel cultures of fibroblasts in the presence of the b-AR antagonist alprenolol. Heat-treatment of this conditioned medium fully prevented the increase in cell proliferation, indicating that the autocrine factor(s) are heat-sensitive proteins. Conclusions: Chronic b -AR stimulation increases proliferation of human cardiac fibroblasts via a mechanism involving increased 2 secretion of heat-sensitive growth factors.
. Introduction
The mechanisms that underlie the detrimental effects of chronic b-AR stimulation in heart failure are therefore of In heart failure patients, myocardial sympathetic nervous immense interest and clinical relevance. activity is increased to compensate for loss of cardiac
The adult heart consists of both myocytes and nonfunction [1, 2] . However, prolonged increases in adrenergic myocytes (fibroblasts, endothelial cells and smooth muscle drive are ultimately damaging to the heart. A number of cells). The vast majority of non-myocytes are cardiac large clinical trials have demonstrated a remarkable benefit fibroblasts, which account for up to two-thirds of the total of b-adrenergic receptor (b-AR) antagonists (b-blockers) cells in the heart. Cardiac fibroblasts are responsible for in reducing the mortality associated with heart failure [3] .
regulating the synthesis and degradation of extracellular matrix (ECM) components in the cardiac interstitium, thereby maintaining the structural integrity of the heart. In the adult, myocardial remodeling is regulated primarily by hormones and growth factors acting on cardiac fibroblasts, 2 .3. Immunocytochemistry resulting in alteration of ECM metabolism and increased cardiac fibroblast proliferation [4, 5] .
Fibroblasts grown on glass coverslips were fixed with To date, most studies on the adverse consequences of 4% paraformaldehyde and permeabilized with 0.1% Triton chronic adrenergic stimulation have focused on the effects X-100 prior to incubation with goat anti-vimentin primary of catecholamines on cardiac myocytes. Catecholamines antibody (Chemicon International, Harrow, UK) at 4 8C are toxic to myocytes and cause cell death and / or hyovernight. After incubation with FITC-conjugated antipertrophy [5] [6] [7] , ultimately contributing to the loss of goat secondary antibody (Jackson ImmunoResearch Labcardiac function associated with heart failure. A key oratories, West Grove, PA, USA) at room temperature for 4 benefit of b-AR blockade in heart failure patients appears h in the dark, coverslips were mounted and cells visualised to be at the level of adverse myocardial remodeling which using a Zeiss LSM-510 confocal microscope. is reduced, or even reversed, in patients receiving bblockers [3] . Despite the key role of cardiac fibroblasts in 2 .4. Determination of b-AR subtype expression using regulating myocardial ECM metabolism, relatively little is RT-PCR known about the chronic effects of b-AR stimulation on 2 cardiac fibroblast function.
Confluent 75-cm flasks of cardiac fibroblasts were We therefore sought to determine whether an additional incubated in serum-free medium (SFM) for 48 h prior to mechanism underlying the detrimental effects of chronic RNA extraction using the SV Total RNA Isolation System b-AR stimulation in heart failure patients is that b-AR (Promega, Southampton, UK). Control human genomic stimulation increases proliferation of human cardiac fi-DNA was extracted from whole blood using the PureGene broblasts, thus contributing to adverse myocardial reGenomic DNA Purification Kit (Gentra Systems, Minmodeling.
neapolis cAMP accumulation over a 12-min period in the presence with 10% FCS, 2 mmol / l L-glutamine, 100 mg / ml penicilof 0.5 mmol / l IBMX, as we have described previously [8] . lin G, 100 mg / ml streptomycin and 0.25 mg/ml amphotericin). Cells were plated into cell culture flasks for 30 2 .6. Measurement of MAPK activation min to allow fibroblasts to adhere. Following removal of non-adherent cells, fibroblasts were cultured to confluence Fibroblasts were incubated in SFM for 24 h before in fresh full growth medium in a humidified atmosphere of incubation with appropriate drugs for 5 min at 37 8C in 5% CO in air at 37 8C, and subsequently passaged by SFM. Mitogen-activated protein kinase (MAPK) activation 2 trypsinization. Experiments were performed on early paswas determined by immunoblotting whole cell homogesage cells (2-5) from up to 15 different patients.
nates with a phospho-specific p44 / 42 MAPK antibody (New England Biolabs, Hitchin, Herts, UK), as we have CM was added every 2 days to parallel cultures of described previously [9] .
fibroblasts previously prepared for proliferation assays, as described above. For heat inactivation experiments, an 2 .7. Cell proliferation studies aliquot of CM was heated to 80 8C for 20 min, then cooled to below 37 8C before addition of FCS and alprenolol. For Cardiac fibroblasts were seeded into 24-well plates dilution experiments, C-CM and ISO-CM were diluted 1:5 (10 000 cells per well) in 1 ml of full growth medium. or 1:10 in SFM before addition of FCS. The feeder flasks After incubation overnight, cells were growth-arrested in were replenished with fresh minimal growth medium (with SFM for 48 h. SFM was then replaced with 1 ml of or without ISO) every 2 days throughout the experiment minimal growth medium (medium containing 2.5% FCS)
for the continued production of CM. containing the appropriate drugs. This time point was designated 'Day 0'. Medium and drugs were replaced 2 .9. Data analysis every 2 days throughout the experiment and cell number was determined in duplicate by trypsinizing and counting Data analysis was performed using GraphPad Prism viable cells using Trypan Blue and a hemocytometer. In (GraphPad Software, San Diego, CA, USA (ISO) were not attributable to non-specific passage effects, were determined using a non-linear regression curve-fitting experiments were performed on cells from different pasprogram. Proliferation curves were compared by calculatsages. Similar proliferative responses to ISO were obing areas under curves and performing one-way analysis of served using cells from passages 2-5 inclusive (data not variance (ANOVA) and two-tailed paired t-tests. All other shown).
data were analysed as appropriate using two-tailed paired t-tests. P,0.05 was considered statistically significant.
.8. Preparation of conditioned medium
In order to investigate whether b-AR stimulation could 3 . Results induce cell proliferation in an autocrine manner, we prepared conditioned medium from fibroblasts exposed to 3 .1. Human cardiac fibroblasts express the b -AR 2 b-AR stimulation, then studied its effects on cell prolifersubtype coupled to cAMP production and MAPK ation in the following way. 'Feeder' flasks were prepared activation 2 by seeding fibroblasts into 25-cm flasks (100 000 cells per flask) in 10 ml of full growth medium. After incubation Immunocytochemical staining with anti-vimentin antiovernight, growth medium was replaced with SFM for 48 body confirmed that .98% of cells cultured from biopsies h. SFM was then exchanged for 10 ml of minimal growth of human right atrial appendage were fibroblasts ( Fig. 1 ). medium to produce control conditioned medium (C-CM), Analysis of mRNA expression using RT-PCR revealed that or minimal growth medium supplemented with 1 mmol / l these cells express the b -AR, but not the b -AR (Fig. 2 , 2 1 ISO to produce ISO-CM. After 48 h, CM was collected lane 2). As a positive control, we detected expression of and centrifuged to remove cellular debris. After addition of both b-AR subtypes in a human genomic DNA sample alprenolol (1 mmol / l), with or without FCS (2.5%), this (Fig. 2, lane 1) . No PCR products were detected in the GAPDH. Primer specificity was confirmed by PCR analysis of human genomic DNA (lane 1). The PCR products observed were of the predicted molecular sizes.
fibroblast RNA samples in the absence of reverse transcriptase (Fig. 2, lane 3) , confirming that the samples were not contaminated with genomic DNA. RNA integrity was confirmed by amplification of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (Fig. 2) . 118,551 (Tocris, Bristol, UK), with IC values of 6.162.5 cell proliferation we exposed fibroblasts to different con-50 and 6.361.0 nmol / l, respectively (Fig. 3B) . The b -AR centrations of ISO in minimal growth medium (2.5% FCS) 1 selective antagonist atenolol (CN Biosciences) did not for up to 6 days and measured changes in cell numbers inhibit cAMP production at concentrations up to 100 (Fig. 5A ). Fibroblasts grown in minimal growth medium nmol / l (Fig. 3B) .
alone (control) underwent a low level of proliferation that ISO also stimulated activation of p44 / 42 MAPK in resulted in a 50.5619.8% increase in cell number over a cultured human cardiac fibroblasts in a concentration-6-day period. No further increase in proliferation was dependent manner (EC 52.560.8 nmol / l), as determined observed when fibroblasts were treated with 0.1 nmol / l 50 by immunoblotting whole cell homogenates with a phos-ISO over the same period (P50.952). However, cardiac pho-specific MAPK antibody (Fig. 4A) . ISO-induced fibroblasts incubated in the presence of 10 nmol / l or 1 mmol / l ISO showed an enhanced rate of proliferation delayed proliferative response suggested that the mecha-(P50.108, P50.029, respectively) (Fig. 5A ). This resulted nism by which ISO enhanced proliferation was indirect in an increase in cell number of 67.6615.7 and and possibly due to secretion of growth factors that 109.7615.3%, respectively, after 6 days. In comparison, subsequently increased proliferation in an autocrine manfull growth medium (10% FCS) induced a 193.2652.6%
ner. To test this hypothesis, we prepared conditioned increase in cell number compared with control after 6 days media by treating cardiac fibroblasts with either minimal (n55; data not shown). The effects of ISO on cell growth medium alone (C-CM) or supplemented with 1 proliferation were confirmed to be mediated via the bmmol / l ISO (ISO-CM) for 48 h. We then investigated 2 AR, as the proliferative response was inhibited by ICIwhether these CM could increase proliferation in parallel 118,551, but not atenolol (Fig. 5B) .
cultures of fibroblasts. We had previously observed that the Many physiological responses to b-AR stimulation are ISO-induced increase in cell proliferation was dependent mediated via activation of adenylyl cyclase [10] . We on the presence of FCS (data not shown). We therefore therefore determined the effects of forskolin, a direct supplemented both C-CM and ISO-CM with fresh 2.5% activator of adenylyl cyclase, on human cardiac fibroblast FCS to replace any serum-derived factors that may have proliferation. Although forskolin stimulated cAMP probeen depleted by the fibroblasts in the feeder flasks during duction (Fig. 6A ) and MAPK activation (Fig. 6B ) in a the 2-day production of CM. Alprenolol (1 mmol / l) was concentration-dependent manner, it failed to stimulate also added to the CM to negate any growth-promoting fibroblast proliferation (Fig. 6C) .
effects of ISO-CM that were due to residual ISO. As shown in Fig. 7A (columns 3 and 4) , treatment of 3 .3. b-AR stimulation increases cardiac fibroblast cardiac fibroblasts with ISO-CM for 6 days increased the proliferation via an autocrine mechanism cell number by 6065% over that observed with C-CM. This compared with a 72615% increase induced by ISO in Although ISO increased cardiac fibroblast proliferation control cells (Fig. 7A, columns 1 and 2 ). C-CM increased over a 6-day period, the effect was not apparent until 3-4 cell number by 60618% over untreated control cells (Fig.  days after the initial exposure to ISO (Fig. 5A ). This 7A, columns 1 and 3) due to the additional 2.5% FCS added to the CM. This effect was abolished if the additional 2.5% FCS was omitted (Fig. 7A, column 5) . Furthermore, the ability of ISO-CM to increase cell proliferation was also prevented in the absence of fresh 2.5% FCS (Fig. 7A, column 6 ). Heating the CM to 80 8C prior to addition of 2.5% FCS and alprenolol completely b-AR subtype that is expressed by human cardiac fibroblasts. Firstly, RT-PCR demonstrated that these cells express the b -AR, but not the b -AR (Fig. 2) . Secondly, 2 1 the preferential stimulation of cAMP production by epinephrine compared with norepinephrine ( Fig. 3A) is indicative of a b -AR-mediated response. Thirdly, the 2 ability of both alprenolol and ICI-118,551, but not atenolol, to abolish ISO-induced cAMP production (Fig.  3B ) and MAPK activation (Fig. 4B) further supports a major role for the b -AR in these cells.
2
Using radioligand-binding studies, it has been previously observed that the b -AR accounts for 30-40% of total 2 b-AR expression in human atrium and 20-30% in human ventricle, with the remainder being attributed to the b -AR 1 [10] . However, the expression of b-AR subtypes by cardiac myocytes and fibroblasts may well differ. Functional evidence exists for the co-expression of b -AR and 1 b -AR subtypes in human cardiac myocytes [11, 12] . 2 However, our present observations in human, and those previously in rat [13] [14] [15] , support the conclusion that cultured cardiac fibroblasts express predominantly the b -2 AR subtype.
The present study provides the first report of a proliferative effect of catecholamines on human cardiac fibroblasts. Previous animal studies have shown that catecholamines stimulate DNA synthesis via the b-AR in adult rabbit and neonatal rat cardiac fibroblasts [13, [16] [17] [18] . However, the identity of the b-AR subtypes involved, and whether increased DNA synthesis translated into increased cell number, were not investigated in any of these studies. Our data take these interesting observations an important stage further and clearly demonstrate that chronic b -AR 2 stimulation increases proliferation of human cardiac fibroblasts, as measured by increases in cell number. ISO similar level to that observed with ISO, without activating MAPK. This directly contrasts with our finding in human prevented the growth-promoting activity of ISO-CM (Fig. cardiac fibroblasts, where a range of concentrations of 7A, columns 7 and 8). Upon dilution of ISO-CM (1:5 and forskolin (1 nmol / l-10 mmol / l) did not increase cell 1:10), the stimulatory effect on fibroblast proliferation was proliferation even though intracellular cAMP levels were abolished (Fig. 7B) . elevated and MAPK was activated (Fig. 6 ).
Our results with forskolin indicate that cAMP generation, together with subsequent MAPK activation, do not 4 . Discussion provide a sufficient stimulus for proliferation of human cardiac fibroblasts. Indeed, at higher concentrations of FSK The present study is the first to identify the predominant there was a trend towards reduced proliferation (Fig. 6C ), although this was not statistically significant (control production in cultured rat vascular smooth muscle cells versus 10 mmol / l FSK, P50.099). In rat cardiac fibro- [32] . blasts, a number of previous studies have demonstrated a
In the present study, we report for the first time that the growth-inhibitory effect of cAMP [20] [21] [22] , although a predominant b-AR subtype expressed by human cardiac stimulatory effect has also been reported [19] . The diffibroblasts is the b -AR. Stimulation of the b -AR resulted 2 2 ferential effects of ISO and FSK on the increase in cell in cAMP production, MAPK activation and cell proliferproliferation may be due to differences in the size and ation. Our current observations differ from those reported duration of the cAMP and MAPK signals generated by in animal cardiac fibroblasts in that b -AR-induced prolif-2 these two agents. Alternatively, additional signal transduceration in the human cells occurred via an indirect mechation pathways may be responsible for the proliferative nism. We demonstrate here that this increase in prolifereffect of ISO. For example, the phosphatidylinositol-3-ation was due to enhanced secretion of one or more kinase pathway is activated following b -AR stimulation heat-sensitive autocrine factors. Cardiac fibroblasts are 2 in rat cardiac fibroblasts [23] , and was shown very recently known to secrete a variety of different growth factors and to be necessary for b-AR-mediated DNA synthesis in adult we are currently determining the precise identity of the rat cardiac fibroblasts [24] . The phosphatidylinositol-3-autocrine factor(s) involved using neutralizing antibodies kinase pathway is also required for platelet-derived growth and specific receptor antagonists. factor (PDGF)-induced DNA synthesis in human cardiac A number of large clinical trials have demonstrated that fibroblasts [25] .
b-AR antagonists improve cardiac performance and sigThe proliferative effect of ISO on human cardiac nificantly reduce mortality in heart failure patients [3, 33] . fibroblasts that we observed was not apparent until [3] [4] Investigation of the underlying mechanisms has focused days after the initial exposure to ISO (Fig. 5A ). This is mainly on the role of b-ARs in cardiac myocytes [6, 7] . clearly different from some other reports in animal cardiac
The effects of chronic b-AR stimulation on cardiac fibroblasts where marked DNA synthesis was observed fibroblast behaviour have received less attention and have within 24 h of b-AR stimulation [16] [17] [18] and significant been almost exclusively studied in animal models. The cell proliferation within 48 h [19] . However, one report in relative merits of b -selective blockade versus non-selec-1 keeping with our findings in human cells showed that tive b-blockade in the treatment of heart failure is the DNA synthesis was not apparent until 72 h after initial subject of current debate [3, 34] . Our observations that exposure to ISO in neonatal rat cardiac fibroblasts [13] .
human cardiac fibroblasts express the b -AR, and that 2 Another recent study reported that treatment with norepichronic b -AR stimulation increases fibroblast prolifer-2 nephrine for ,48 h inhibited rat cardiac fibroblast proliferation, offer a further rationale for potential differential ation, but longer treatments (48-96 h) resulted in increased effects of commonly used b-blockers according to their cell proliferation [22] .
selectivity. The delayed proliferative response we observed suggested that the stimulatory effect of ISO on cell growth was indirect. We hypothesized that this was due to A cknowledgements increased secretion of one or more factors capable of inducing cell proliferation in an autocrine manner. We This study was supported by research grants from the therefore collected conditioned medium from cardiac British Heart Foundation. We are grateful to the carfibroblasts treated with ISO for 48 h (ISO-CM) and diothoracic surgeons at the Leeds General Infirmary, showed that it caused a significant increase in fibroblast particularly Mr D.J. O'Regan, for the provision of heart proliferation in parallel cultures in the presence of the tissue. b-AR antagonist alprenolol (Fig. 7A) . Heating the ISO-CM to 80 8C completely abolished the proliferative response, suggesting that the secreted autocrine factor is a R eferences bioactive protein or peptide, rather than a chemical mediator.
